atazanavir sulfate has been researched along with Cognitive Decline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonora, S; Calcagno, A; De Benedetto, I; Guastamacchia, G; Trunfio, M | 1 |
| Couraud, PO; Hauser, KF; Jahr, FM; Leibrand, CR; McClay, JL; McRae, M; Palasuberniam, P; Patel, S; Weksler, B | 1 |
1 review(s) available for atazanavir sulfate and Cognitive Decline
| Article | Year |
|---|---|
A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugs.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Astrocytes; Atazanavir Sulfate; Benzoxazines; Central Nervous System; Cognitive Dysfunction; Cyclopropanes; Dideoxynucleosides; Endothelial Cells; HIV Infections; Humans; Neurons; Nevirapine; Nitriles; Oligodendroglia; Pyrimidines | 2020 |
1 other study(ies) available for atazanavir sulfate and Cognitive Decline
| Article | Year |
|---|---|
Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function
Topics: Atazanavir Sulfate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Cell Line; Cognitive Dysfunction; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Methamphetamine; Multidrug Resistance-Associated Proteins; Rhodamines; tat Gene Products, Human Immunodeficiency Virus; Transendothelial and Transepithelial Migration; Zonula Occludens-1 Protein | 2017 |